Covid becoming ‘pandemic of the unvaccinated' To view this email as a web page,
click here | | Webinar: New Trends in Virtual Trials Monday, July 26 | 11am ET / 8am PT Last year, clinical trial platform developer Medable raised $91M in private funding, amid the COVID-19 pandemic that touched off huge demand among pharma companies looking to initiate “siteless” or virtual clinical trials. Explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now. |
CDC director: COVID-19 morphing into ‘pandemic of the unvaccinated’ as cases spike by 70% Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims to add 1,000 new staffers over 5 years COVID-19 tracker: Pfizer's jab trumps Sinovac in new study; J&J doses to arrive in Africa Fierce Pharma Asia—Sinovac, Sinopharm to supply 500M vaccine doses to COVAX; 2 approvals for Seagen-Astellas' Padcev CMS launches all-out effort to boost ACA signups before special enrollment period ends Featured Story | By Robert King COVID-19 cases are up nearly 70% and reaching 30,000 infections per day primarily due to low vaccination rates in some parts of the country, according to the CDC. read more |
| |
|---|
|
| | Webinar: COVID-19 Virus Sequencing for Drug Development Wednesday, July 28 | 10:30am ET / 7:30am PT As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now. |
Top Stories By Fraiser Kansteiner Regeneron laid plans for a six-year, $1.8 billion expansion at its existing Westchester County campus, according to the New York Governor’s office. The expansion will see the company grow its New York headcount by 1,000 over the next five years. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The vaccine from Pfizer and BioNTech produced an antibody response roughly 10 times greater than the shot from China's Sinovac, a new study found. African countries will receive their first shipment of donated U.S. doses in the coming days. And more. read more By Kevin Dunleavy Sinovac and Sinopharm will supply up to 500 million vaccine doses to the COVAX worldwide relief effort. Seagen-Astellas gained two FDA approvals for bladder cancer treatment Padcev. BGI Group and the Chinese military reportedly shared data on millions of pregnant women who have used BGI's genetic test. And more. read more By Robert King CMS is launching an all-out marketing push to get more signups on ACA exchanges before a special enrollment period ends on Aug. 15. read more |
|
